CURRICULUM VITAE Viviana Elizabeth Horigian, M.D, MHA

1. Date: January 23, 2021

I. Personal

2. Name: Viviana Elizabeth Horigian, M.D., MHA

3. Office Phone: (305) 243-4305

4. Address: 6021 SW 64th Avenue, Miami, FL 33143

5. Current Academic Rank: Professor

5A. Current Track of Appointment: Educator Track

6. Primary Department: Public Health Sciences

7. Secondary or Joint Appointment: N/A

II. Higher Education

8. Institutional:

2016-2018 Masters in Health Administration, College of Health Sciences and Professions, Ohio University.

1993-1996 Specialty Degree in Psychiatry, School of Medicine, University of Buenos Aires (Spanish: Universidad de Buenos Aires- UBA), Buenos Aires, Argentina1

1986-1991 M. D., with honors, School of Medicine, University of the Savior (Spanish: Universidad del Salvador- USAL), Buenos Aires, Argentina

1981-1985 International Baccalaureate, St Catherine´s School, Buenos Aires, Argentina

9. Non-Institutional:

2000- 2001 Postgraduate in Clinical Research, Studies and Clinical Research Group (Spanish: Grupo de Estudio e Investigación Clínica- GEDIC), Buenos Aires, Argentina

1 Please note that in Argentina in addition to the 3-year residency program, a separate 3-year post graduate degree is required for a specialist in Psychiatry.

1 1997-1999 Postgraduate in Marital and Family Studies and Psychoanalysis, Graduate School for Psychotherapy (Spanish: Escuela de Psicoterapia para Graduados) Buenos Aires, Argentina

1996-1993 Residency in Psychiatry, Italian Hospital of Buenos Aires (Spanish: Hospital Italiano de Buenos Aires), Department of Psychiatry, Buenos Aires, Argentina

1992-1991 Postgraduate Internship: (Rotation in Medicine) Italian Hospital of Buenos Aires (Spanish: Hospital Italiano de Buenos Aires), Buenos Aires, Argentina. (Psychiatry Rotation) Harbor- UCLA, Torrance, Los Angeles, CA

10. Certification and Licensure:

2013 Project Manager Professional- PMP

2004 USMLE-1 U.S. Medical Licensing Examination USMLE-2 Clinical Knowledge U.S. Medical Licensing Examination USMLE-2 Clinical Skills U.S. Medical Licensing Examination

2005 Educational Commission for Foreign Medical Graduates Certification ECFMG

2001 EEG/ Neurofeedback Certificate Program, St. Paul, MN

2001 Biofeedback training, Professional Biofeedback Certificate Program, St Paul, MN

III. Experience

11. Academic:

2020- Present Professor, Educator Track, Department of Public Health Sciences, University of Miami School of Medicine, Miami, Florida

2015-2020 Associate Professor, Department of Public Health Sciences, University of Miami School of Medicine, Miami, Florida

2008-2014 Research Assistant Professor, Center for Family Studies, Department of Public Health Sciences, University of Miami School of Medicine, Miami, Florida

2005-2007 Research Assistant Professor, Center for Family Studies, Department of Psychiatry & Behavioral Sciences, University of Miami School of Medicine, Miami, Florida.

2002-2005 Assistant Scientist, Center for Family Studies, Department of Psychiatry & Behavioral Sciences, University of Miami Miller School of Medicine

1999-2001 Clinical Assistant Professor of Psychiatry, School of Medicine, University of Buenos Aires, (Spanish: Universidad de Buenos Aires- UBA), Buenos Aires, Argentina.

2 1989-1991 Teaching Assistant Student for Histology, Embryology Cytology and Genetics, assigned by the Dean of the School of Medicine, University of the Savior (Spanish: Universidad del Salvador- USAL) Buenos Aires, Argentina.

12. Hospital Appointments:

1999- 2001 Director of Smoking Cessation Program, Italian Hospital of Buenos Aires (Spanish: Hospital Italiano de Buenos Aires), Department of Psychiatry, Outpatient Clinic, Buenos Aires, Argentina.

1996-2001 Admission and Outpatient Diagnostic Evaluation Psychiatrist, Italian Hospital of Buenos Aires (Spanish: Hospital Italiano de Buenos Aires), Department of Psychiatry, Outpatient Clinic, Buenos Aires, Argentina.

1996-1999 Instructor and Resident in Chief, Residency Program in Psychiatry, Italian Hospital of Buenos Aires (Spanish: Hospital Italiano de Buenos Aires), Department of Psychiatry, Buenos Aires, Argentina.

13. Non- Academic:

2009-2008 Program consultant for To Life Center, Weight loss, Wellness and Lifestyle Change, Miami, Florida.

2001-1999 Psychiatrist in Consultation at Rehabilitation and Surgery Clinic (Spanish: Clínica de Rehabilitación y Cirugía -CIAREC) Buenos Aires, Argentina.

1987-1986 English Teacher for (2nd, 6th and 7th grade) Mekhitarista School of Buenos Aires (Spanish: Colegio Mekhitarista de Buenos Aires) Buenos Aires, Argentina.

14. Military:

None

3 IV. Publications

15. Books and Monographs Published:

a. Horigian, V.E., & Szapocznik, J. Brief Strategic Family Therapy: Thirty-five years of interplay among theory, research and practice in adolescent behavior problems and drug abuse. In L.M. Scheier (Ed.), APA Handbook of Drug Prevention: Research, Intervention Strategies and Practice, Washington, DC, US: American Psychological Association, pp 249-265, 2015.

b. Medina-Mora, ME., Noknoy, S., Cherpitel, C., Real, T., Pérez Velasco, R., Marín Navarrete, R. Amador, N., Horigian, V.E. Trials of Interventions for People with Alcohol Use Disorders. In G.Thornicroft & V. Patel (Ed.), Global Mental Health Trials, Oxford University Press, pp 179- 202, 2014.

c. Robbins, M.S., Horigian, V.E., Szapocznik, J., & Ucha, J. Treating Hispanic youth using brief strategic family therapy. In J. R. Weisz & A. E. Kazdin (Eds.), Evidence-based psychotherapies for children and adolescents (2nd ed.), New York: Guilford, pp 375-390, 2010.

d. Robbins, M.S., Szapocznik, J. & Horigian, V.E. Brief strategic family therapy for adolescents with behavior problems. In J.H. Bray (Ed.), Handbook of Family Psychology, Wiley Blackwell, United Kingdom, pp 416-430 2008.

e. Robbins, M.S., Horigian, V. E., & Szapocznik, J. Brief Strategic Family Therapy. In N. Jainchill (Ed.), Understanding and Treating Adolescent Substance Use Disorders. Kingston, New Jersey: Civic Research Institute, Inc., pp 10-23, 2007.

f. Horigian, V.E. Suarez-Morales, L., Robbins, M.S., Zarate, M., Mayorga, C.C., Mitrani, V.B., & Szapocznik, J. Brief Strategic Family Therapy for adolescents with behavior problems. In J.L. Lebow (Ed.) Handbook of clinical family therapy, , Hoboken, NJ: Wiley. pp. 73-102, 2005.

g. Horigian, V.E. Psiquiatría Psicodinámica en la Práctica Clínica [Spanish Translation of the book Psychodynamic psychiatry in clinical practice (3rd Ed., G. Gabbard, M.D., Ed.). Editorial Médica Panamericana, Buenos Aires, Argentina. [Panamerican Medical Press], 2002.

16. Juried or Refereed Journal Articles or Exhibitions:

a. Godley S, Aumiller B, Horigian VE, Khalil, N., Kruger, J., Pennel, C., Youatt, E., & Kiviniemi, M. T. Evidence-Based Educational Practices for Public Health: How We Teach Matters. Pedagogy in Health Promotion. Evidence-Based Educational Practices for Public Health: How We Teach Matters. Pedagogy in Health Promotion. December 2020. doi:10.1177/2373379920978421

b. Horigian VE, Schmidt RD, Feaster DJ. Loneliness, Mental Health, and Substance Use among US Young Adults during COVID-19. J Psychoactive Drugs. 2020 Oct 28:1-9. doi: 10.1080/02791072.2020.1836435. Impact factor: 1.859

4 c. Greer TL, Walker R, Rethorst CD, Northrup TF, Warden D, Horigian VE, Silverstein M, Shores-Wilson K, Stotts AL, Trivedi MH. Identifying and responding to trial implementation challenges during multisite clinical trials. J Subst Abuse Treat. 2020 Mar;112S:63-72. doi: 10.1016/j.jsat.2020.02.004. Impact factor: 2.728

d. Boudreau DM, Lapham G, Johnson EA, Bobb JF, Matthews AG, McCormack J, Liu D, Campbell CI, Rossom RC, Binswanger IA, Yarborough BJ, Arnsten JH, Cunningham CO, Glass JE, Murphy MT, Zare M, Hechter RC, Ahmedani B, Braciszewski JM, Horigian VE, Szapocznik J, Samet JH, Saxon AJ, Schwartz RP, Bradley KA. Documented opioid use disorder and its treatment in primary care patients across six U.S. health systems. J Subst Abuse Treat. 2020 Mar;112S:41-48. doi: 10.1016/j.jsat.2020.02.001. Impact factor: 2.728

e. Lapham G, Boudreau DM, Johnson EA, Bobb JF, Matthews AG, McCormack J, Liu D, Samet JH, Saxon AJ, Campbell CI, Glass JE, Rossom RC, Murphy MT, Binswanger IA, Yarborough BJH, Bradley KA, Ahmedani B, Amoroso PJ ,Arnsten JH, Bart G, Braciszewski JM, Cunningham CO, Hechter RC, Horigian VE, Liebschutz JM, Loree AM, Matson TE, McNeely J, Merrill JO, Northrup TF, Schwartz RP, Stotts AL, Szapocznik J, Thakral M, Tsui JI, Zare M. Prevalence and treatment of opioid use disorders among primary care patients in six health systems. Drug Alcohol Depend. 2019, 207:107732. doi: 10.1016/j.drugalcdep.2019.107732. Impact factor: 3.46

f. St Onge JE, Cata AM, Horigian VE. Integration of Public Health in LCME Accredited Medical Schools in Florida: A Survey Based Study.Cureus. 2019, 11(7):e5213. doi: 10.7759/cureus.5213. Impact factor: g. Marín- Navarrete, R. Pérez Lopez, A., Medina Mora, M.E., Horigian V.E. Development and evaluation of addiction treatment programs in Latin America. Curr Opin Psychiatry 2018, 31:306–314 doi:10.1097/YCO.0000000000000434. Impact Factor: 4.266 h. Rodriguez VJ, LaCabe RP, Privette CK, Douglass KM, Peltzer K, Matseke G, Mathebula A, Ramlagan S, Sifunda S, Prado GW, Horigian V, Weiss SM, Jones DL. The Achilles' heel of prevention to mother-to-child transmission of HIV: Protocol implementation, uptake, and sustainability. SAHARA-J, Dec;14(1):38-52, 2017. Impact Factor: 1.33 i. Horigian, V.E, Anderson AR, Szapocznik, J. Family Based Treatments for Adolescent Substance Abuse Child Adolesc Psychiatr Clin N Am. Oct;25(4):603-28, 2016. doi: 10.1016/j.chc.2016.06.001 Impact Factor: 1.68 j. Marín-Navarrete R., Medina-Mora M.E., Horigian V.E., Salloum IM, Villalobos-Gallegos L, Fernández-Mondragón J.Co-Occurring Disorders: A Challenge for Mexican Community-Based Residential Care Facilities for Substance Use.J Dual Diagn. Jul-Dec;12(3-4):261-270, 2016.

5 Impact Factor : 1.180

6 k. Marín-Navarrete R, Horigian VE, Medina-Mora ME, et al. Motivational enhancement treatment in outpatient addiction centers: A multisite randomized trial. Int J Clin Health Psychol. 17(1):9–19, 2016. doi:10.1016/j.ijchp.2016.05.001. Impact factor: 3.9 l. Hatch-Maillette M, Wells EA, Doyle SR, Brigham GS, Daley D, DiCenzo J, Donovan D, Garrett S, Horigian V.E., Jenkins L, Killeen T, Owens M, Perl HI. Predictors of 12-Step Attendance and Participation for Individuals With Stimulant Use Disorders. Journal of Substance Abuse Treatment. Sep;68:74-82, 2016. doi: 10.1016/j.jsat.2016.06.007. Impact Factor : 2.46 m. Horigian, V. E., Espinal, P. S., Alonso, E., Verdeja, R. E., Duan, R., Usaga, I. M., ... Feaster, D. J. (2016). Readiness and barriers to adopt evidence-based practices for substance abuse treatment in Mexico. Salud Mental, 39(2), 77-84. doi: 10.17711/SM.0185-3325.2016.004 n. Horigian V.E., Anderson AR, Szapocznik J. Taking Brief Strategic Family Therapy from Bench to Trench: Evidence Generation Across Translational Phases. Family Process. Sep;55(3):529- 42, 2016 doi: 10.1111/famp.12233. Impact Factor : 2.187 o. Jacobs P, Estrada YA, Tapia MI, Quevedo Terán AM, Condo Tamayo C, Albán García M, Valenzuela Triviño GM, Pantin H, Velazquez MR, Horigian V.E., Alonso E, Prado G. Familias Unidas for high risk adolescents: Study design of a cultural adaptation and randomized controlled trial of a U.S. drug and sexual risk behavior intervention in Ecuador. Contemporary Clinical Trials. Mar; 47:244-53, 2016. doi: 10.1016/j.cct.2016.01.014. Impact factor: 2.052 p. Peltzer K., Prado G., Horigian V.E., Weiss S., Cook R., Sifunda S., & Jones D. Prevention of mother-to-child transmission (PMTCT) implementation in rural community health centres in Mpumalanga province, South Africa. Journal of Psychology in Africa Vol. 26, Iss. 5, 2016 Impact factor: 0.207 q. Horigian, V. E., Feaster, D. J., Robbins, M., Brincks, A., Ucha, J., Rohrbaugh, M., Shoham, V., Bachrach, K., Miller, M., Burlew, K., Hodgkins, C. C., Carrion, I., Silverstein, M., Werstlein, R., & Szapocznik, J. A cross-sectional assessment of the long-term effects of Brief Strategic Family Therapy for adolescent substance use. American Journal on Addictions 24(7):637-45, 2015. Impact factor:1:929 r. Horigian, V. E., Marín-Navarrete, R., Verdeja, R., Alonso, E., Pérez, M. A., Berlanga, C., Mondragon, J. F., Medina-Mora, M. E., & Szapocznik, J. Technology transfer for the implementation of a clinical trials network of mental health and substance abuse in Mexico. -. Revista Panam Salud Publica. 38(3):233-42, 2015. Impact factor: 0.85 s. Horigian, V. E., Feaster, D. J., Brincks, A., Robbins, M. S., Perez, M. A., & Szapocznik, J. The effects of Brief Strategic Family Therapy (BSFT) on parent substance use and the association between parent and adolescent substance use. Addictive Behaviors, 42, 44-50, 2015. Impact Factor: 2.44 t. Kyle, T. L., Horigian, V. E., Tross, S., Gruber, V. A., Pereyra, M., Mandler, R. N., . . . Metsch, L. R. Uptake of HIV testing in substance use disorder treatment programs that offer on-site testing. AIDS and Behavior, 536-542, 2014–Impact Factor: 3.49

7 u. Marín Navarrete, R., Templos Nunez, L., Eloisa Hernandez, A., Villalobos- Gallegos, L., Verdeja, R.E., Alonso, E., Feaster, D.J. Horigian, V.E. Characteristics of a Treatment- Seeking Population in Outpatient Addiction Treatment Centers in Mexico, Substance Use and Misuse, 49(13), 1784-1794, 2014 - Impact Factor :1.226 v. Kiluk, B.D., Dreifuss, J.A., Weiss, R.D., Horigian, V.E., & Carroll, K.M. Psychometric properties of a Spanish-language version of the Short Inventory of Problems Psychology of Addictive Behaviors, 27 (3):893-900, 2013. w. Stoutenberg M., Lee D.C., Sui X., Hooker S., Horigian,V.E., Perrino T. & Blair S. Prospective Study of Alcohol Consumption and the Incidence of Metabolic Syndrome in U.S. Men. British Journal of Nutrition, 110(5):901-910, 2013. x. Winhusen, T., Somoza, E., Lewis, D., Kropp, F., Horigian, V.E., & Adinoff, B. Frontal Systems Deficits in Stimulant-Dependent Patients: Evidence of Pre-illness Dysfunction and Relationship to Treatment Response. Drug and Alcohol Dependence, 127(1-3):94-100, 2012. y. Horigian, V.E., Weems, C.F., Robbins, M.S., Feaster, D.J., Ucha, J., Miller, M., & Werstlein, R. Reductions in Anxiety and Depression Symptoms in youth receiving substance use treatment. American Journal on Addictions, 22(4) 329-337, 2013.

z. Warden, D., Trivedi, M.H., Greer, T.G., Nunez, E., Granneman, B.D., Horigian, V.E., Somoza, E., Ring, K., Kyle, T., & Szapocznik, J. Rationale and methods for site selection for a trial using a novel intervention to treat stimulant abuse. Contemporary Clinical Trials, 33(1) 29-37, 2012.

aa. Robbins, M.S., Feaster, D.J., Horigian, V.E., Rohrbaugh, M., Shoham, V., Bachrach, K., Miller, M., Burlew, K., Hodgkins, C., Carrion, I., VanDeMark, N., Schindler, E., Werstlein, R., & Szapocznik, J. Brief Strategic Family Therapy versus Treatment as Usual: Results of a Multi- Site Randomized Trial for Substance Using Adolescent. Journal of Consulting and Clinical Psychology, 79(6), 713-727, 2011.

bb. Robbins, M.S., Feaster, D.J., Horigian, V.E., Puccinelli, M., Henderson, C., & Szapocznik, J. Therapist Adherence in Brief Strategic Family Therapy for Adolescent Drug Abusers. Journal of Consulting and Clinical Psychology, 79, 43–53, 2011.

cc. Weems, C. F., Feaster, D. J., Horigian, V.E., & Robbins, M. S. Parent and child agreement on anxiety disorder symptoms using the DISC predictive scales. Assessment,; 18, 213–216, 2011.

dd. Robbins, M.S., Alonso, E., Horigian, V.E., Bachrach, K., Carrión, I.S., Hodgkins, C.C., Miller, M., Schindler, E., Van DeMark, N., Henderson C., & Szapocznik, J. Transporting Clinical Research to Community Settings: Implementing Brief Strategic Family Therapy (BSFT) in Community Substance Abuse Treatment. Addiction Science & Clinical Practice, 5(2), 59-61, 2010.

ee. Horigian, V.E., Robbins, M.S., Dominguez, R., Ucha, J., & Rosa, C.L. Principles for defining adverse events in behavioral intervention research: Lessons from a family focused adolescent drug abuse trial. Clinical Trials, 7, 58–68, 2010.

ff. Feaster, D.J., Robbins, M.S., Henderson, C., Horigian, V.E., Puccinelli, M.J.,Burlew, K., Szapocznik, J. Equivalence of family functioning and externalizing in adolescent substance users of different race/ethnicity. Journal of Substance Abuse Treatment, 38, 8 S1:S113-S124, 2010.

9 gg. Robbins, M., Szapocznik, J., Horigian, V. E., Feaster, D. , Puccinelli, M, Jacobs, P., Burlew, K., Werstlein, R., Bachrach, K., & Brigham, G. Brief Strategic Family Therapy for Adolescent Drug Abusers: A Multi-Site Effectiveness Study. Contemporary Clinical Trials 30, 269–278, 2009.

hh. Robbins, M.S., Horigian, V.E., & Szapocznik, J. Brief Strategic Family Therapy: Ein empirisch überprüfter ansatz zur reduction von Verhaltensproblemen jugendlicher [Brief Strategic Family Therapy: An empirically-validated intervention for reducing adolescent behavior problems]. Prax. Kinderpsychol. Kinderspcyhiat [Practice of Child Psychology and Child Psychiatry], 57, 381-400, 2008.

ii. Robbins, M.S., Horigian, V.E., & Szapocznik, J. Brief Strategic Family Therapy: An Empirically Validated Family Therapy for adolescents with Disruptive Behavior. Journal of Brief, Systemic, and Strategic Therapies, 1 (1), 39-62, 2007.

jj. Horigian, V.E., Lage, O.G., & Szapocznik, J. Cultural differences in adolescent drug abuse. Adolescent Medicine Clinics [Invited, Special issue, on Substance Abuse Among Adolescents]. 17, 469-498. 2006.

kk. Horigian, V.E., Robbins, M.S., & Szapocznik, J. Brief Strategic Family Therapy. Brief Strategic and Systemic Therapy: European Review [inaugural issue], 1, 251-271, 2004.

ll. Feaster, D.J., Robbins, M.S. Horigian, V.E., & Szapocznik, J. Statistical issues in multi-site effectiveness trials: The Case of Brief Strategic Family Therapy for adolescent drug abuse treatment. Clinical Trials, 1, 428-439, 2004.

mm. Horigian, V.E. “Sexo: aspectos biológicos de una variable compleja” [Sex: Biological aspects of a complex variable] Vertex. Revista Argentina de Psiquiatría [Vertex. Argentine Journal of Psychiatry], XI, 189-194, 2000.

nn. Horigian, V.E. “Psicosis anfetamínica, actualización bibliográfica y presentación de un caso clínico” [Amphetamine induced Psychoses, research update and case presentation.]. Clepios, Una Revista Para Residentes de Salud Mental [Clepios: A Journal for Mental Health Residents], III, (3), 102-105, 1997.

17. Other Works, Publications and Abstracts:

a. Feaster, D.J., Robbins, M.S., Horigian, V.E., & Szapocznik, J. Brief Strategic Family Therapy: Statistical design of a multi-site effectiveness trial for adolescent drug abuse treatment. Controlled Clinical Trials, 24, 43S-2405. [Abstracts of Symposium Presentations at the Annual Meeting of the Society for Prevention Research: “Research to Policy”]. Washington, D.C., 2003.

b. Horigian, V.E., Espinal-Nunez, P.S., Feaster, D.J., Alonso, E., Verdeja, R.E., Usaga, I., Perez, A. & Marin-Navarrete, R. (2014). Readiness and barriers to adopt evidence-based practices for substance abuse treatment in Mexico. Alcohol and Alcoholism Vol. 49, No. S1, pp. i1–i69, 2014.

c. Horigian, V. E., Feaster, D. J., Robbins, M. S., Brincks, A., Perez, M. A., & Szapocznik, J. (2014). Long-term effects of Brief Strategic Family Therapy for adolescent substance users [Abstract]. Drug and Alcohol Dependence, 140(0),02.265, 2014.

10 d. Horigian, VE, Feaster, DJ, Duan, R, Perez, MA, Penn, P, Mandler, RN, Metsch, LR. “Substance Use Treatment as a Preventive Strategy for Depression and Sexual Risk Behavior: A Secondary Analysis of NIDA Clinical Trials Network Protocol CTN 0032”, In program and Abstracts of the 19th International AIDS Conference, Washington, DC, 2012.

18. Other Works Accepted for Publication:

V. Professional

19. Funded Research Performed:

ACTIVE

Title: Florida Node Alliance of the National Institute on Drug Abuse Clinical Trials Network. Grant: # U10-DA13720 Funding agency: National Institutes on Drug Abuse (NIDA) Principal Investigator: Dra Jose Szapocznik, Lisa Metsch, Daniel Feaster Role: Executive Director since 2013, Project Director 2010- 2013, Node Coordinator 2006- 2010) Total: $25,500,500 (infrastructure only) Dates: 2000-2025

Participation in Protocols implemented in the Florida Node Alliance Title: CTN 0074: Primary Care Opioid Use Disorders Treatment Trial (PROUD) – Phase 2 Grant: # U10-DA13720 Funding agency: National Institutes on Drug Abuse (NIDA) Role: University of Miami Principal Investigator Total Supplement: $1,024,935 Dates: 2017-2021

Title: CTN0080- Medication Treatment for Opioid Use Disorder in Expectant Mothers (MOMs): A Pragmatic Randomized Trial Comparing Two Buprenorphine Formulations Role: Node Protocol PI Grant #: UG1DA013720-19 Funding Agency: National Institute on Drug Abuse Total: $1,553,740 Dates: 6/1/2019 – 5/31/2024

Title: CTN0100- Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy Role: Node Protocol PI Funding Agency: New York University Grossman School of Medicine Total: $877,819 Dates: 6/1/2020 – 2/1/2025

Title: Culturally-focused HIV Advancements through the Next Generation for Equity (CHANGE) Training Program Role: Principal Investigator Funding Agency: National Institute on Mental Health Total: $335,268 Dates: 04/01/2021-03/31/2025

11 Title: Scaling a Parenting EBI for Latinx Youth Mental Health in Primary Care

12 Role: Co - Investigator Funding Agency: National Institute on Mental Health Total: $ 530,486 (year 1) Dates: 04/01/2021-03/31/2025

COMPLETED

Title: Opioid Addiction Training and Prevention Education Program Role: Faculty trainer Funding Agency: Department of Children & Families/ Contract through FSU Total: $6,589 Dates: 4/1/19 – 6/30/20

Title: “Organization of American States (OAS) - Inter-American Drug Abuse Control Commission (CICAD) and the University of Miami (UM): First Hemispheric Drug Use Prevention Forum,” Role: Principal Co Investigator. Grant #: CFA02-2020. Funding Agency: Department of Public Health Sciences – Copeland Awards Total Supplement= $14,167 Dates: 3/1/2020- 10/31/2020

Title: Effects of COVID-19’s social restrictions on loneliness and psychosocial symptomatology Role: Principal Investigator Grant #: PG013150 Funding Agency: University of Miami, Office of the Vice Provost for Research Total Supplement: $34,399 Dates: 04/08/2030 – 08/08/2020

Title: “Journal of Public Health Student Capstones “ Role: Principal Co Investigator. Grant #: CFA01-2019 Funding Agency: Department of Public Health Sciences – Copeland Awards Total Supplement= $ 19,700 Dates: 2/2019- 9/2019

Title: Evidence Based Strategies to combat the opioid epidemic: Current Approaches to HIV Behavioral Health and Substance Use Treatment and Their Availability in South Florida Role: Co Principal Investigator Grant#: CFA002 Total: $26,000 Date: 1/2018- 7/2018

Participation in Protocols implemented in the Florida Node Alliance Title: CTN 0074: Primary Care Opioid Use Disorders Treatment Trial (PROUD) – Phase 1 Grant: # U10-DA13720 Funding agency: National Institutes on Drug Abuse (NIDA) Role: University of Miami Principal Investigator Total Supplement: $45,300 Dates: 2017

Title: The University of Miami- O&M Collaboration to Establish a Multifaceted Research Infrastructure for Public Health Agency: The University of Miami Institute for the Advanced Studies of the Americas Role: Investigator Total: $7500 Date: 2017

13 Participation in Protocols implemented in the Florida Node Alliance Title: CTN 0051: Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT) Grant: # U10-DA13720 Funding agency: National Institutes on Drug Abuse (NIDA) Role: University of Miami Principal Investigator Total Supplement: $940,776 Dates: 2014-2017

Title: Technology Transfer for the Implementation of Randomized Clinical Trials with the NIDA CTN Standards at the National Institutes of Psychiatry in Mexico Grant: # S-INLEC11GR020 Funding Agency: US Department of State Principal Investigaor: Viviana E. Horigian Total: $844,689 Dates: 2011-2014

Title: Implementing Comprehensive PMTCT & HIV Prevention for South African Couples – Collaboration for Implementation Science (Admin Supp) Grant: #R01HD078187 Funding Agency: National Institute of Health/ PEPFAR Principal Investigator: Deborah Jones Role: Investigator Responsible for delivering training in implementation science Total: $321,861. Dates: 2014-2015

Title: CTN 0060: Computer-Facilitated Intervention for Adolescent Marijuana Use Prevention (CAMP) Funding agency: National Institutes on Drug Abuse (NIDA) Grant: # U10-DA13720 Role: Investigator Total Supplement: $740,564 Dates: 2015-2016

Title: CTN-0047: Screening, Motivational Assessment, Referral, and Treatment in Emergency Departments (SMART-ED) Funding agency: National Institutes on Drug Abuse (NIDA) Grant: # U10-DA13720 Role: University of Miami Principal Investigator Total supplement: $1,111,271 (Year 01) Dates: 2010- 2013

Title: Stimulant Reduction Intervention using Dosed Exercise (STRIDE) Funding agency: National Institutes on Drug Abuse (NIDA) Grant: # U10-DA13720 Role: University of Miami Principal Investigator Total supplement: $3,300,000 Dates: 2009- 2013

Title: Stimulant Abuser Groups to Engage in 12-Step (STAGE-12): Evaluation of a Combined Individual-Group Intervention to Reduce Stimulant Use by Increasing 12-Step Involvement Funding agency: National Institutes on Drug Abuse (NIDA) Grant: # U10-DA13720 Role: University of Miami Principal Investigator Total supplement: $1,000,000 Dates: 2008- 2011

Title: An evaluation of neurocognitive function, oxidative damage, and their association with treatment outcomes in metamphetamine and cocaine abusers 14 Funding agency: National Institutes on Drug Abuse (NIDA) Grant: # U10-DA13720 Role: University of Miami Principal Investigator Total Supplement: $300,000 Dates: 2008- 2011

Title: Brief Strategic Family Therapy versus Treatment as Usual: Extended Follow-up for Drug Using Adolescents. Funding agency: National Institutes on Drug Abuse (NIDA) Grant: # 1RC2DA028864 Funding Agency: National Institutes on Drug Abuse Role: Co-Investigator Total: $ 1,390,000 Dates: 2009-2012

Title: Brief Strategic Family Therapy for Adolescent Drug Abuse” Principal Investigator: Dr. Jose Szapocznik Funding agency: National Institutes on Drug Abuse (NIDA) Role: National Project Coordinator (2002-2006), and Investigator (since 2007) Total supplement: $12,000,000 (Florida Node Costs only- Lead and 5 sites) Dates: 2001-2010

20. Editorial Responsibilities:

Present-2019 Co Editor in Chief Journal of Public Health Student Capstones Present-2014 Editorial Board Member of Revista Salud Mental, Instituto Nacional de Psiquiatría, Mexico Present-2016 Ad-Hoc reviewer for the Journal of Substance Use Treatment .

21. Professional and Honorary Organizations:

Present- 2016 Academy of Medical Educators at the University of Miami Present - 2016 American Public Health Association Present -2012 Society of Clinical Trials Present- 2009 National Hispanic Science Network 2011 Asociación de Conductas Adictivas y Patología Dual de Iberoamérica 2001-1996 American Psychiatric Association (International Member) 2001-1996 Asociación de Psiquiatras Argentinos (APSA) 1992 New York Academy of Sciences

22. Honors and Awards:

2018 Mentorship award, Delta Omega Beta Sigma Chapter at the University of Miami 2015 NIDA International Award of Excellence in International Leadership 1992 Honor Diploma, School of Medicine, Universidad del Salvador, Buenos Aires, Argentina 1985 Oratory Competition Award, National Council of Private Institutes (Spanish: Consejo de Rectores de Institutos Privados) Buenos Aires, Argentina 1985 Essay Award by University of Belgrano (Spanish: Universidad de Belgrano) Buenos Aires, Argentina 1985 Outstanding Student Award, St Catherine’s High School, Buenos Aires, Argentina.

15 23. Post-Doctoral Fellowships:

None

24. Other Professional Activities:

Present- 2020 Member of the Stimulant Treatment Taskforce of the National Drug Abuse Clinical Trials Network

Present- 2018 Member of the Youth Special Interest Group of the National Drug Abuse Treatment Clinical Trials Network

Present -2009 Member of the Minority Special Interest Group of the National Drug Abuse Treatment Clinical Trials Network

2018-2015 Member of the Data Science Health Care Task Force of the National Drug Abuse Treatment Clinical Trials Network

2014 Member of the Registry Special Interest Group of the National Drug Abuse Treatment Clinical Trials Network.

2014 Member of the Adolescent Special Interest Group of the National Drug Abuse Treatment Clinical Trials Network

2017-2009 Member of the Psychopharmacology Interest Group of the National Drug Abuse Treatment Clinical Trials Network.

2017-2012 Member of the Design and Analyses Special Interest Group of the National Drug Abuse Treatment Clinical Trials Network.

2001-1999 Member of the Anti- Tobacco Group Hospital Italiano (Grantahi)

2001-2000 Member of the Addiction Committee for Psychoanalitical Federation of Latin America (Spanish: Federacion Psicoanalitica de Latinoamerica -FEPAL)

2001-1999 Member of the Addiction Committee, Asociación de Psiquiatras Argentinos

1999-1996 Member of the Epistemology Committee, Asociación de Psiquiatras Argentinos

Invited and Keynote Presentations

a. Robbins, M.S. & Horigian, V.E. Recruitment and retention challenges. Presented at the National Institute on Drug Abuse’s Clinical Trials Network Meeting on Recruitment and Retention in Clinical Trials. Rockville, Maryland, April, 2007

b. Horigian, V.E Major Public Health Challenges of Today. Presentation to first year undergraduate college students. First Year U, October, 2018.

c. Horigian, V.E. The Impact of the Opioid Epidemic in the Pediatric Population: Challenges for the Undeserved Communities. Workshop, Children’s Health Fund Annual Meeting, October, 2018.

16 Presentations

1. Collins, J, Shmueli-Blumberg D, Jelstrom , E, Hoffman K A, Ponce Terashima J, Korthuis PT, Horigian VE Deciding the Extent of Certified Translations in a U.S.-Based Substance Abuse Treatment Clinical Trial: The CHOICES-2 Experience. Presented at the 82nd Virtual Annual Meeting, College on Alcohol and Drug Dependence, June 2020.

2. Horigian, VE, St George, S. Giving Students a Voice: Introducing Discussion-based Activities in a Flipped Graduate Course. Presented at the Association of Schools and Programs of Public Health, Annual Retreat, Academic Affairs Section, June 2020

3. Horigian, V. E, Robles, N. Yue, Pan, Feaster Daniel, OUD and mental health outcomes among substance users in Puerto Rico following Hurricane Maria, Presented at 81st Annual Meeting, College on Alcohol and Drug Dependence, June 2019.

4. Carrico, A.W., Horigian V.E., Duan, R. , Feaster D.J., Gooden L. K., Rodriguez, A., Sorensen, J., Matheson, T., Tross, S., Colfax G., Metzger, D., Jacobs, P., del Rio, C., Metsch, L. Multilevel Predictors of suicidality among HIV + Substance Users in 11 US cities. Presented at the Conference of Retroviruses and Opportunistic Infections, March, 2019.

5. Horigian, V.E. The Impact of the Opioid Epidemic in the Pediatric Population: Challenges for the Undeserved Communities. Workshop, Children’s Health Fund Annual Meeting, October, 2018.

6. Noriega Esquives, B. Duan R., Feaster DJ., Horigian VE, The impact of substance use disorders on diabetes quality of care measures. Poster presented at the College on Drug and Alcohol Dependence, June 2018.

7. Barbosa-Leiker, C., Campbell, A., Hatch-Maillette, M., Lapham, G. Boudreau, D.,Takral, M. , Tsui, J. Yarborough, B.J., Arnsten, J., Binswanger, I., Stotts, A., Loree, A., Braciszewski, J., Glass, J., Horigian, V.E, Hutcheson, R., Campbell, C. Bart G., , Bradley K. Sex differences in co-occurring substance use, mental health and pain disorders, in primary care patients diagnosed with opioid use disorders. Poster presented at the College on Drug and Alcohol Dependence, June 2018.

8. Boudreau, D., Lapham, G., Johnson, E., Bobb, J., Mattheus. A., McCormack, J., Liu, D., Campbell, C., Rossom, R., Binswanger, I., Yarborough, B.J., Arnsten, J., Cunningham, Chinazo, Glass, J., Murphy, M., Amoroso, P., Mohammad, Z., Hechter, R., Ahmedani, B., Braciszwewski, J., Horigian, V.E., Szapocznik, J., Samet J., , Saxon,A., Bradley K. Documented prevalence of opioid use disorder and its treatment across 8 diverse health care systems in the US. Poster presented at the College on Drug and Alcohol Dependence, June 2018.

9. Horigian, V.E., Perrino, T. Strengthening Learning by Teaching Students to Teach: The Public Health Learning Collaboratory. University of Miami’s 2017 Faculty Showcase, May, 2017.

10. Horigian, V.E., Muir, J., & Szapocznik, J. Parallel Processes in Family Therapy Implementation Research: The Adventures of BSFT. In panel (Panel Chair: M. Rohrbaugh),

17 Think Systematically, Act Empirically: Varda Shoham’s Legacy for Psychotherapy Research. Jerusalem: 2016 Annual Meeting of the Society for Psychotherapy Research. June, 2016.

11. Horigian, V.E., & Szapocznik, J. Insights from 35 years of research on Brief Strategic Family Therapy. In panel (Panel Chair: Jay Lebow), 20/20 hindsight: Insights from programs of family and child research over several decades. Jerusalem: 2016 Annual Meeting of the Society for Psychotherapy Research, June 2016

12. Horigian VE, Perrino T, Kornfeld J. A Learning Collaboratory to develop student's core professional and practice skills: An innovative approach to improving community health. Presented at the Annual Meeting of the American Public Health Association, Chicago, IL, November, 2015.

13. Villalobos-Gallegos, Marín-Navarrete, R., Feaster DJ Horigian VE Medina Mora ME Latent Class Analysis of sexual risky behavior in patients with substance use disorders Profile of Psychiatric Symptoms In A Sample of Patients With Co‐Occurring Disorders. Presented at the Annual Meeting Of the National Institute of Psychiatry in Mexico, Mexico City, October, 2015.

14. Marín-Navarrete, R. Medina Mora, Horigian VE. Co-occuring Disorders In Mutual-Aid Residential Centers For Addiction Care In Mexico: Results of a Cross-Sectional Study. Presented during NIDA Clinical Trials Network (CTN) Steering Committee meeting, Gaithersburg, MD, April, 2015.

15. Marin-Navarrete, R. Medina Mora ME, Horigian, VE Co-occuring disorders in residential centers: A public health concern. Presented at the IV International Congress of Dual Disorders Addictions and other Mental Disorders, Barcelona, April, 2015.

16. Horigian, V.E., Marin Navarrete, R.A, Medina- Mora, M.E., Szapocznik, J. Using Clinical Trials to Develop and Implement Evidence Based Interventions in Mexico. Presented as part of the panel on Implementation Science and Evidence Based Treatments in Latin America: International Collaboration Challenges and Opportunities, NIDA International Forum. Phoenix, AZ, June, 2015.

17. Szapocznik, J., & Horigian, V. Translating T1-T4 in a Behavioral Intervention: An Example using the Brief Strategic Family Therapy® BSFT® Model for the Treatment of Adolescent Drug Abuse. Presented as a poster the Annual Cane Search Symposium, University of Miami Miller School of Medicine, Miami, FL, February, 2015.

18. Horigian, V.E., Espinal-Nunez, P.S., Feaster, D. J, Alonso, E., Verdeja, R., Usaga, I., Perez, A. & Marin-Navarrete, R. Readiness and barriers to adopt evidence-based practices for substance abuse treatment in Mexico. Presented at the Annual Cane Search Symposium, University of Miami Miller School of Medicine, Miami, FL, February, 2015.

19. Szapocznik, J., & Horigian, V. Translating Behavioral Technologies to Practice & Back: Interplay between Theory, Research & Practice: An Example using the Brief Strategic Family Therapy® BSFT® Model for the Treatment of Adolescent Drug Abuse. Presented at the Second Annual Cane Search Symposium to Showcase Scientific Collaboration, Promote Research Resources, University of Miami Miller School of Medicine, Miami, FL, February, 2014.

20. Szapocznik, J., & Horigian, V. Translating Behavioral Technologies to Practice & Back: Interplay between Theory, Research & Practice “An Example using the Brief Strategic Family Therapy® BSFT® Model for the Treatment of Adolescent Drug Abuse”. Presented as invited

18 guest speaker at the “Susan Patrick Olson Lecture”, University of New Mexico, Albuquerque, NM, May, 2014.

21. Horigian, V.E., Espinal-Nunez, P.S., Feaster, D. J, Alonso, E., Verdeja, R., Usaga, I., Perez, A. & Marin-Navarrete, R. Readiness and barriers to adopt evidence-based practices for substance abuse treatment in Mexico, presented as a poster at the 16th World Congress of Psychiatry “Focusing on Access, quality and Humane Care”, Madrid, Spain, September, 2014.

22. Marín-Navarrete, R., Horigian, V.E, Fernandez Mondragon, J., Verdeja, R. E., Alonso, Templos-Nuñez, L., Eloisa- Hernandez, A., Feaster, D.J., Sanchez- Huesca, R., De La Fuente, A., Lima- Rodriguez., C. , Berlanga, C. , Medina- Mora, M.E. A multisite randomized controlled trial of Motivational Enhancement Treatment in outpatient addiction care centers in Mexico, presented as a poster at the 76th Annual Meeting of The College on Problems on Drug Dependence, June, 2014.

23. Fernandez Mondragon, J., Horigian, V.E., Graue- Moreno, J., Alonso, E., Verdeja, R., Bucai – Harari, L., De la Fuente, A., Berlanga, C., Marin Navarrete, R. “Safety reporting in randomized clinical trials for behavioral interventions in Mexico”, presented as a poster at the 76th Annual meeting of The College on Problems on Drug Dependence, June, 2014.

24. Horigian, V.E, Marín-Navarrete, R., Verdeja, R.E., Alonso, E., Berlanga, C., Medina- Mora, M.E., Szapocznik, J. “Technology Transfer for the Implementation of a Clinical Trials Network for Substance Abuse and Mental Health in Mexico”, presented a poster at the 167th Annual Meeting of the American Psychiatric Association, New York, May, 2014.

25. Horigian, V.E “Brief Strategic Family Therapy for Adolescent Drug Users: new results” presented as part of a panel on advances in family therapy at the 15th International Conference on Addictions organized by Centros de Integracion Juvenil, Cancun, December, 2013.

26. Marín-Navarrete, R., Horigian, V.E., Fernández-Mondragón, J., Verdeja, R.E., Alonso, E., Templos-Nuñez, L., Eliosa-Hernández, A., Feaster, D. Sánchez-Huesca, R., De la Fuente- Martín, A., Lima-Rodríguez, C., Berlanga, C., Medina-Mora, ME. “Motivational Enhancement Therapy to improve retention and treatment outcomes in Mexican substance abuse treatment seekers: preliminary results”, presented as a poster at the 15th International Conference organized by Centros de Integracion Juvenil, Cancun, December, 2013.

27. Fernández-Mondragón, J., Graue-Moreno, J., Bucay-Harari, L., Horigian,V.E., Alonso, E., Verdeja, RE, De La Fuente Martín, A., Berlanga, C., Marín-Navarrete, R. “Safety report and adverse events in a behavioral clinical trial in Mexico”, presented as a poster at the 15th International Conference organized by Centros de Integración Juvenil, Cancún, December, 2013.

28. Villalobos-Gallegos, L., Eliosa-Hernández, A., Pérez-López, A., Fernández-Mondragón, J., Templos-Nuñez, L., Larios-Chávez, L., Horigian, V.E., Marín-Navarrete, R. “Substance Use variables and related consequences: Analyses from a Randomized Clinical Trial implemented in Mexico” presented as a poster at the 15th International Conference organized by Centros de Integración Juvenil, Cancun, December, 2013.

29. Templos-Nuñez, L., Jimena Cervera-Ballesteros, J., Eliosa-Hernández, A., Gómez-Valencia, G., Galván-Sosa, D., Larios-Chávez, L., Luis Villalobos-Gallegos, L., Horigian, V.E., Marín- Navarrete, R. “What happens behind doors?: Analyses of therapeutic elements in Treatment as Usual sessions of a randomized clinical trial for addictions” presented as a poster at the 15th International Conference organized by Centros de Integración Juvenil, Cancun,

19 December, 2013.

30. Horigian, V.E. “A decade of experience of the National Drug Abuse Treatment Clinical Trials Network: Bridging the Gap between Research and Practice to improve Drug abuse treatment. Results from Behavioral Interventions” Presented as part the XXVII Research Annual Meeting of the National Institute of Psychiatry, Mexico City, October, 2013.

31. Horigian, V.E. “Crossing borders and building bridges: Overview of a successful international collaboration to improve substance abuse treatment research and practice in Mexico”, presented as part of the panel on Technology Transfer for the Implementation of a Clinical Trials Network on Drug Abuse and Mental Health in Mexico, National Hispanic Science Network, Bethesda, October, 2013.

32. Horigian, V.E, Marín Navarrete, R., Medina Mora, M.E., Verdeja, R.E, Alonso, E., Berlanga C., Sanchez- Huesca, R., Lima- Rodriguez, De la Fuente- Martin, A. “Development of a Clinical Trials Network to test and disseminate evidence based practices to treat addiction and mental disorders in Mexico” poster presented at The College of Problems on Drug Dependence, San Diego, June, 2013.

33. Horigian V.E., Feaster D.J., Brincks A., Robbins M.S., Perez M.A. & Szapocznik J. “Long term effects of Brief Strategic Family Therapy for Adolescent Drug Users”, poster presented at The College on Problems on Drug Dependence, San Diego, June, 2013.

34. Killeen T., Korte J., Brigham G., Horigian V E., Carlini C, Donovan D. “Impact of a 12 Step Facilitation Intervention on Tobacco Smoking Outcomes in Community Treatment Programs”, poster presented at 75th Annual Meeting of The College on Problems on Drug Dependence, San Diego, June, 2013.

35. Horigian, V. E., Feaster, D.J., Robbins M.S., Szapocznik, J. Brief Strategic Family Therapy. presented at the Race and Ethnic Minorities Research Symposium, Washington, DC, April, 2013

36. Horigian, V.E., “A decade of experience of the National Drug Abuse Treatment Clinical Trials Network: Bridging the Gap between Research and Practice to improve Drug abuse treatment.” presentation delivered as part of plenary panel “The transference of Technology for Mental Health Services”, at the Congreso Internacional de Centros de Integración Juvenil, Cancún, December, 2012.

37. Horigian, V.E., “BSFT for adolescent drug abusers: Four decades of development, research and clinical practice.” Presentation delivered as part of the panel on Family Therapy Congreso Internacional de Centros de Integración Juvenil, Cancún, December, 2012.

38. Horigian, V.E., “Bridging the Gap between Research and Practice: A decade of experience of the National Drug Abuse Treatment Clinical Trials Network”, presentation delivered as part of the symposium titled Implementation Science: Translating the Efficacy of Drug Abuse Treatment Research into the Community at the 12th International Congress of Behavioral Medicine. Budapest, August 29th, 2012.

39. Horigian, V.E., Feaster, DJ, Duan, R, Perez, MA, Penn, P, Mandler, RN, Metsch, LR. “Substance Use Treatment as a Preventive Strategy for Depression and Sexual Risk Behavior: A Secondary Analysis of NIDA Clinical Trials Network Protocol CTN0032”, poster presented at the XIX International AIDS Conference, Washington, DC, July 26th 2012.

20 40. Horigian, V.E. Treatment intervention Science and Clinical Trials in Drug Abuse. Workshop at the Interdisciplinary Research Training Institute on Hispanic Drug Abuse, National Hispanic Science Network Summer Institute, Los Angeles, CA, June 24th 2012.

41. Horigian, V.E., Feaster, D.J., Brincks, A., Robbins, M.S., Perez, M.A. & Szapocznik, J. The effects of Brief Strategic Family Therapy (BSFT) on parent substance use and the association between parent substance use and adolescent substance use. Poster presentation at the 74th Annual Meeting of the College on Problems of Drug Dependence. Palm Springs, CA, June 9- 14th 2012.

42. Feaster, D.J., Horigian, V.E., Duan, R., Perez, M.A., Penn, P., Mandler, R.N., & Metsch, L.R. “Substance Use Treatment as a Preventive Strategy for Depression and Sexual Risk Behavior: A Secondary Analysis of NIDA Clinical Trials Network Protocol CTN0032.” Oral presentation at the Society for Prevention Research Annual Meeting. Washington, DC May, 2012.

43. Horigian, V.E. “Participant barriers to compliance.” Presented as part of the panel, Dealing with Treatment Compliance in Clinical Trials on Inherently Low-Compliant Populations: What to do at the Design, Monitoring, and Analysis Stages (Invited Session 30), at the 33rd Annual Meeting of the Society for Clinical Trials, Miami, FL, May 23rd 2012.

44. Horigian, V.E. “Spanish MET”. Presented as part of the symposium, Secondary Analyses of MET/MI Studies, at the Spring NIDA Steering Committee Meeting. Atlanta, GA, April 18th 2012.

45. Horigian, V.E. Treatment intervention Science and Clinical Trials in Drug Abuse. Workshop at the Interdisciplinary Research Training Institute on Hispanic Drug Abuse, National Hispanic Science Network Summer Institute, Houston, TX, June 7th 2011.

46. Horigian, V.E. Robbins, M.S., Alonso, E., Bachrach, K., Carrión, I.S., Hodgkins, C.C., Miller, M., Schindler, E., Van DeMark, N., Ucha, J., & Szapocznik, J. Transporting clinical research into community settings: Implementing Brief Strategic Family Therapy in Community Substance Abuse Treatment. Presented as a poster at the 138th American Public Health Association Annual Meeting, Denver, CO, November 6-10th 2010.

47. Horigian, V.E., Robbins, M.S., Feaster, D.J. “Predictors of Outcomes in Brief Strategic Family Therapy for Adolescent Drug Users.” Presented as part of the symposium, Beyond Main Findings of NIDA Multi-Site Treatment Trials for Youth with Substance Use Disorders: What Works and for Whom?, at the 57th American Academy of Child and Adolescent Psychiatry Annual Meeting, New York, October 26-31, 2010.

48. Robbins, M.S., Feaster, D.J., & Horigian, V.E. “Adherence-outcome links in family therapy with drug abusing adolescents.” Presented as part of the panel, Inside the Black Box: Treatment Process for Youth Externalizing Behaviors, at the 118th Annual Meeting of the American Psychological Association. San Diego, California, August, 2010.

49. Horigian, V.E. Treatment intervention Science and Clinical Trials in Drug Abuse. Workshop at the Interdisciplinary Research Training Institute on Hispanic Drug Abuse, National Hispanic Science Network Summer Institute, Houston, June 2010.

50. Horigian, V.E., Weems, C., Ucha-Vieta, J., Robbins, M.S. Psychiatric Comorbidity among Youth Receiving Substance Abuse Treatment: Prevalence and the Effects of Intervention in Reducing Symptoms and Incidence. Posted presented at the American Psychiatric Association, Annual Meeting, San Francisco, May, 2009. 21 51. Robbins, M.S., Puccinelli, M.J., Horigian, V.E., & Ucha-Vieta, J. Results of a multi-site effectiveness trial: Brief Strategic Family Therapy for adolescent drug abuse. Presented at the 117th annual convention of the American Psychological Association, Toronto, Canada, August, 2009.

52. Horigian, V.E, Szapocznik, J., Rosa, C., Jacobs, P. The Clinical Trials Network as a model for implementing randomized clinical trials. Presented at the RECIA meeting, National Hispanic memberScience Network, Bethesda, Maryland. , October, 2008.

53. Robbins, M.S., Szapocznik, J., Horigian, V.E., & Puccinelli, M. Brief strategic family therapy for adolescent drug abusers. Presented at the Annual Meeting of the American Psychiatric Association. Washington, D.C. May, 2008.

54. Robbins, M.S., Szapocznik, J., Feaster, D., Horigian, V.E., & Teszler, N. Measuring therapist adherence in brief strategic family therapy. Paper presented as part of the panel on Implementation Measurement with Evidence-Based Practices (Lisa Saldana, Chair) at the Joint Meeting on Adolescent Treatment Effectiveness. Washington, D.C., April, 2007

55. Horigian, V.E. Overview of BSFT Protocol and the Lead Node’s Role in bringing the Protocol to a Spanish Language Country. Presented at the NIDA Health Disparities Conference, Atlanta, Georgia, October, 2005

56. Garcia de Amusquibar, A., Finkelsztein, C., Horigian, V.E., De Simone, C., Traumas de la Infancia y trastornos de la Alimentación. Presented at the Salon del Consejo, Hopsital Italiano (Paper selected within the 10 best scientific papers for the Premio Dr Jose Teszler a la Investigación Clínica).

57. Robbins, M.S., & Horigian, V.E. Brief strategic family therapy: An empirically validated intervention. Presented at the 53rd Annual Session of the University of Utah School on Alcoholism and Other Drug Dependencies, Salt Lake City, Utah, June, 2004

58. Horigian, V.E. “Infarto de miocardio y depresión: Experiencia del servicio de psiquiatría del Hospital Italiano” [Myocardial infarction and depression: Experience of the Department of Psychiatry at the Italian Hospital of Buenos Aires.]. Symposium presented at the XVI Argentine Conference on Psychiatry [“XVI Congreso Argentino de Psiquiatría”]. Sponsored by the Argentine Psychiatric Association (APSA) [“Asociación de Psiquiatras , May, 2000

59. Horigian, V.E. “Género y psiquiatría: Perspectivas del Servicio de Psiquiatría del Hospital Italiano de Buenos Aires” [Gender and psychiatry: Perspectives of the psychiatry service at the Italian Hospital of Buenos Aires] Symposium presented at the XVI Argentine Conference on Psychiatry [“XVI Congreso Argentino de Psiquiatría”]. Sponsored by the Argentine Psychiatric Association (APSA) [“Asociación de Psiquiatras Argentinos/APSA”]. Mar del Plata, Province of Buenos Aires, Argentina. , May, 2000

60. Horigian, V.E. “La razón de estar contigo” [The reason for being with you] Paper presented at the First Meeting of Family and Couple Psychoanalysts [“Primer Encuentro de Psicoanalistas de Familia y Pareja”]. Buenos Aires, Argentina, May 1999

61. Horigian, V.E. Gender and antipsychotic response. Poster presented at the XI World Congress of Psychiatry. Sponsored by WPA, Hamburg, Germany, August, 1999

62. Horigian, V.E. Brief reactive psychoses in personality disorders. Poster presented at the XI 22 World Congress of Psychiatry. Sponsored by WPA, Hamburg, Germany, August, 1999

63. Horigian, V.E. “El suicidio a la luz de la cultura” [Suicide from a cultural perspective]. Symposium presented at the Regional Symposia of the Argentine Psychiatric Association [“Simposio Regional de la Asociación Argentina de Psiquiatras”], Buenos Aires, Argentina., October, 1999

64. Horigian, V.E. “Criterios del servicio de psiquiatría del Hospital Italiano en internaciones conflictivas”[Criteria of the Department of Psychiatry at the Italian Hospital of Buenos Aires for conflictive hospitalizations ]. Symposium presented at the XV Argentine Conference on Psychiatry. Sponsored by the Argentine Psychiatric Association (APSA) [“XV Congreso Argentino de Psiquiatría, Asociación de Psiquiatras Argentinos/APSA]. Mar del Plata, Provincia de Buenos Aires, Argentina., April, 1999

65. Horigian, V.E. “Tratamientos del paciente con trastornos de difícil abordaje” [Treatment of patient with disorders of difficult approach] Symposium presented at the XV Argentine Conference on Psychiatry. Sponsored by the Argentine Psychiatric Association (APSA) [“XV Congreso Argentino de Psiquiatría, Asociación de Psiquiatras Argentinos/APSA]. Mar del Plata, Provincia de Buenos Aires, Argentina., April, 1999

66. Horigian, V.E. “Suicido. Observaciones del servicio de psiquiatría del Hospital Italiano para el tratamiento del paciente borderline grave” [Suicide: Observations of the Department of Psychiatry at the Italian Hospital of Argentina on the treatment of seriously borderline patients]. Symposium presented at the XV Argentine Conference on Psychiatry. Sponsored by the Argentine Psychiatric Association (APSA) [“XV Congreso Argentino de Psiquiatría, Asociación de Psiquiatras Argentinos/APSA]. Mar del Plata, Provincia de Buenos Aires, Argentina, April, 1999

67. Horigian, V.E. “Fundamentos del Servicio de Psiquiatría del Hospital Italiano para el tratamiento del paciente borderline grave” [Fundamentals of the Department of Psychiatry at the Italian Hospital of Argentina for the treatment of the seriously borderline patient]. Symposium presented at the XIV Argentine Conference on Psychiatry. Sponsored by the Argentine Psychiatric Association (APSA) [“XIV Congreso Argentino de Psiquiatría, Asociación de Psiquiatras Argentinos/APSA]. Mar del Plata, Provincia de Buenos Aires, Argentina., April, 1998

68. Horigian, V.E. “Experiencias del Hospital Italiano sobre descompensaciones agudas en los trastornos de la personalidad” [Experience of the Italian Hospital of Argentina on acute breakdowns in Borderline Personality Disorder.] Presented at the XIV Argentine Conference on Psychiatry. Sponsored by the Argentine Psychiatric Association (APSA) [“XIV Congreso Argentino de Psiquiatría, Asociación de Psiquiatras Argentinos/APSA]. Mar del Plata, Provincia de Buenos Aires, Argentina., April 1998

69. Horigian, V.E, Perez Rivera, R., Trajterman, A., Canovi, A. Personality disorders in panic attack. Poster presented as New Research at the 151st Annual Meeting of the American Psychiatric Association, Toronto, Canada, June, 1998

70. Horigian, V.E. “Vigencia de la Psicosis Puerperal como entidad nosológica “[“Post partum psychoses as nosological entity of current use ”] [Presented at the XII Argentine Conference on Psychiatry. Sponsored by the Argentine Psychiatric Association (APSA) [“XII Congreso Argentino de Psiquiatría, Asociación de Psiquiatras Argentinos/APSA]. San Miguel del Tucumán, Provincia de Tucumán, Argentina, Octubre, 1996

23 71. Horigian, V.E. “Experiencia del Servicio de Psiquiatría del Hospital Italiano en la internación del paciente borderline” [Experiences of the Psychiatric Service, Italian Hospital of Buenos Aires, in the hospitalization of borderline patients]. Presented at the IV Argentine Conference on Psychiatry. Sponsored by the Argentine Psychiatric Association (AAP) [“IV Congreso Internacional de Psiquiatría, Asociación Argentina de Psiquiatras (AAP)]. Buenos Aires, Argentina. October, 1996

VI. Teaching

25. Teaching Awards Received:

None

26. Teaching Specialization

26a. Courses Taught

EPH 644: Fundamentals of Program Evaluation, Designed and co- taught this asynchronous online course, for MPH candidates, Department of Public Health Sciences, Miami, Florida, Spring 2020

EPH 679: The Learning Collaboratory for MPH candidates, Department of Public Health Sciences, Miami Florida. Course co taught: Fall 2016, Spring 2017, Fall 2017, Spring 2018, Fall 2018, Spring 2019, Fall 2019, Spring 2020, Fall 2020.

EPH 584-04: Special Topics: The Learning Collaboratory for MPH candidates, Department of Public Health Sciences, Miami, Fl. Course co taught: Fall 2014, Spring 2015, Fall 2015, Spring 2016

Fundamentos de los ensayos clínicos controlados y aleatorizados en psiquiatría y adicciones [ Fundamentals of Randomized clinical trials in psychiatry and addictions ], Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Mexico, August, 2018.

Fundamentos de los ensayos clínicos controlados y aleatorizados en psiquiatría y adicciones [ Fundamentals of Randomized clinical trials in psychiatry and Addiction], Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Mexico, August, 2017.

EPH 604: Clinical Trials. Summer Intensive for MPH & PhD candidates, Department of Public Health Sciences, Miami, Fl. Course taught: Summer 2012, 2013, 2014, 2015, 2016, 2017, 2018, Summer 2019. Designed an asynchronous version of this course and taught Summer 2020.

26b. Development of an Educational Program for the National Institute of Psychiatry in Mexico: Training Modules Taught

January 2012 The Informed Consent Process. Webinar for researchers and practitioners of the Mexican Clinical Trials Network, National Institutes of Psychiatry, Mexico.

January 2012 Assessing for Eligibility for the Motivational Enhancement Therapy Protocol. Webinar for researchers at the National Institutes of Psychiatry, Mexico City.

24 October 2011 Protocol Specific Training for Motivational Enhancement Therapy at the as part of the UM-National Institutes of Psychiatry collaboration project of Technology Transfer for the Implementation of Randomized Clinical Trials, Mexico City.

June 2011 Development of Data Management Center and Systems, Mexico City.

April 2011 Clinical Trials Methodology and Management. Mexico City.

April 2011 Protocol Development: Adaptation of the CTN 0021 METS Randomized Clinical Trials for implementation in Community Treatment Programs in Mexico. Miami, FL.

February 2011 The National Drug Abuse Treatment Clinical Trials Network as a model for transferring evidence practices to clinical settings. Methodology of site selection for the creation of the CTN MEX. Mexico City, DF.

26.c Technology Transfer for the Implementation of the Familias Unidas Program for the Universidad Católica Santiago de Guayaquil, Ecuador and Fundación San Carlos de Maipo, Chile - Training Modules Taught:

July 2015 Fundamentals of Clinical Trials: Methods and Management, Santiago de Chile.

August 2014 Fundamentals of Clinical Trials: Methods and Management, Guayaquil, Ecuador

August 2014 Management of Clinical Trials, Miami, FL

26d.1 Lectures December 2020 The Opioid Epidemic: Treatment and Research. Presentation to Fellows in Anesthesiology, Miller School of Medicine

November 2020 Communities, Context and the Social Determinants of Health. Special Lecture for An introduction to Resilient Building and Community, School of Architecture. Instructor: Dr Sonia Chao

April 2018 Implementation of evidence-based practices in public health. Factors that influence dissemination and implementation for the course in Program Evaluation taught at the Department of Public Health Sciences, University of Miami. Instructor: Dr Kara Riehman

April 2015 Invited Guest Lecturer on Improving Substance Abuse and Mental Health Treatment Practices in Mexico: Implementing a National Drug Abuse Clinical Trials Network for the course in Program Evaluation, taught at the Department of Public Health Sciences, University of Miami. Instructor: Dr. Margaret Byrne.

September 2014. Implementation Science Workshop delivered together with Dr. Guillermo Prado for researchers at the Human Science Research Council in South Africa.

25 October 2014 Invited Guest Lecture on “Mental and Substance Abuse Disorders, What do we know and what can we do about it?” for the Course on Introduction to Public Health, taught to MPH student at the Department of Public Health Sciences, University of Miami. Instructor: Dr. Julie Kornfeld

July 2014 Invited Guest Lecture on “Mental and Substance Abuse Disorders, What do we know and what can we do about it?” for the Course on Introduction to Public Health, taught to MD/MPH student at the Department of Public Health Sciences, University of Miami. Instructor: Dr. Julie Kornfeld

April 2014 Invited Guest Lecturer on Improving Substance Abuse and Mental Health Treatment Practices in Mexico: Implementing a National Drug Abuse Clinical Trials Network for the course in Program Evaluation, taught at the Department of Public Health Sciences, University of Miami. Instructor: Dr. Margaret Byrne.

November 2013 Invited Guest Lecturer on Implementation of a Clinical Trials Network for Mental Health and Substance Abuse in Mexico for the course on Introduction to Disease Prevention, taught at the Department of Public Health Sciences, University of Miami, Instructor: Dr. Guillermo Prado.

December 2009 EPH 584 Special Topics: An introduction to Clinical Trials. Miami, FL.

26d. 2 Trainings for research staff for protocols implemented in the National Drug Abuse Treatment Clinical Trials Network

July 2007 Adverse events and Serious Adverse Events General Concepts and Application in the Brief Strategic Family Therapy (BSFT) for Adolescent Drug Abuse clinical trial, for members of the Clinical Trials Network, National Institutes on Drug Abuse. (2 trainings)

November 2006 Adverse events and Serious Adverse Events General Concepts and Application in the Brief Strategic Family Therapy (BSFT) for Adolescent Drug Abuse clinical trial, for members of the Clinical Trials Network, National Institutes on Drug Abuse. (2 trainings)

August 2006 Adverse events and Serious Adverse Events General Concepts and Application in the Brief Strategic Family Therapy (BSFT) for Adolescent Drug Abuse clinical trial, for members of the Clinical Trials Network, National Institutes on Drug Abuse.

August 2006 Protocol Specific Training for Brief Strategic Family Therapy (BSFT) for Adolescent Drug Abuse clinical trial, for members of the Clinical Trials Network, National Institute on Drug Abuse.

May 2006 Adverse events and Serious Adverse Events General Concepts and Application in the Brief Strategic Family Therapy (BSFT) for Adolescent Drug Abuse clinical trial, for members of the Clinical Trials Network, National Institutes on Drug Abuse. (2 trainings)

May 2006 Protocol Specific Training for Brief Strategic Family Therapy (BSFT) for Adolescent Drug Abuse clinical trial, for members of the Clinical Trials 26 Network, National Institutes on Drug Abuse. (2 trainings)

April 2006 Protocol Specific Training for Brief Strategic Family Therapy (BSFT) for Adolescent Drug Abuse clinical trial, for members of the Clinical Trials Network, National Institutes on Drug Abuse.

April 2006 Adverse events and Serious Adverse Events General Concepts and Application in the Brief Strategic Family Therapy (BSFT) for Adolescent Drug Abuse clinical trial, for members of the Clinical Trials Network, National Institutes on Drug Abuse.

March 2006 Protocol Specific Training for Brief Strategic Family Therapy (BSFT) for Adolescent Drug Abuse clinical trial, for members of the Clinical Trials Network, National Institutes on Drug Abuse.

March 2006 Adverse events and Serious Adverse Events General Concepts and Application in the Brief Strategic Family Therapy (BSFT) for Adolescent Drug Abuse clinical trial, for members of the Clinical Trials Network, National Institutes on Drug Abuse.

March 2006 Good Clinical Practices: Consent and Progress Noting for Brief Strategic Family Therapy (BSFT) for Adolescent Drug Abuse clinical trial, for members of the Clinical Trials Network, National Institutes on Drug Abuse.

March 2006 Data Management and Clinical Data Collection for Brief Strategic Family Therapy (BSFT) for Adolescent Drug Abuse clinical trial, for members of the Clinical Trials Network, National Institutes on Drug Abuse.

February 2006 Adverse events and Serious Adverse Events General Concepts and Application in the Brief Strategic Family Therapy (BSFT) for Adolescent Drug Abuse clinical trial, for members of the Clinical Trials Network, National Institutes on Drug Abuse.

February 2006 Protocol Specific Training for Brief Strategic Family Therapy (BSFT) for Adolescent Drug Abuse clinical trial, for members of the Clinical Trials Network, National Institutes on Drug Abuse.

November 2005 Data Management and Clinical Data Collection for Brief Strategic Family Therapy (BSFT) for Adolescent Drug Abuse clinical trial, for members of the Clinical Trials Network, National Institutes on Drug Abuse.

September 2005 Protocol Specific Training for Brief Strategic Family Therapy (BSFT) for Adolescent Drug Abuse clinical trial, for members of the Clinical Trials Network, National Institutes on Drug Abuse.

September 2005 Adverse events and Serious Adverse Events General Concepts and Application in the Brief Strategic Family Therapy (BSFT) for Adolescent Drug Abuse clinical trial, for members of the Clinical Trials Network, National Institutes on Drug Abuse.

27 September 2005 Data Management and Clinical Data Collection for Brief Strategic Family Therapy (BSFT) for Adolescent Drug Abuse clinical trial, for members of the Clinical Trials Network, National Institutes on Drug Abuse.

September 2005 Recruitment, Retention and Follow up for Brief Strategic Family Therapy (BSFT) for Adolescent Drug Abuse clinical trial, for members of the Clinical Trials Network, National Institutes on Drug Abuse.

August 2005 Adverse events and Serious Adverse Events General Concepts and Application in the Brief Strategic Family Therapy (BSFT) for Adolescent Drug Abuse clinical trial, for members of the Clinical Trials Network, National Institutes on Drug Abuse.

July 2005 Adverse events and Serious Adverse Events General Concepts and Application in the Brief Strategic Family Therapy (BSFT) for Adolescent Drug Abuse clinical trial, for members of the Clinical Trials Network, National Institutes on Drug Abuse.

June 2005 Protocol Specific Training for Brief Strategic Family Therapy (BSFT) for Adolescent Drug Abuse clinical trial, for members of the Clinical Trials Network, National Institutes on Drug Abuse. (2 trainings)

May 2005 Protocol Specific Training for Brief Strategic Family Therapy (BSFT) for Adolescent Drug Abuse clinical trial, for members of the Clinical Trials Network, National Institutes on Drug Abuse.

May 2005 Adverse events and Serious Adverse Events General Concepts and Application in the Brief Strategic Family Therapy (BSFT) for Adolescent Drug Abuse clinical trial, for members of the Clinical Trials Network, National Institutes on Drug Abuse.

May 2005 Data Management and Clinical Data Collection for Brief Strategic Family Therapy (BSFT) for Adolescent Drug Abuse clinical trial, for members of the Clinical Trials Network, National Institutes on Drug Abuse.

May 2005 Data Collection on Clinical Measures for Brief Strategic Family Therapy (BSFT) for Adolescent Drug Abuse clinical trial, for Therapists of the BSFT protocol, Clinical Trials Network, National Institutes on Drug Abuse.

March 2005 Protocol Specific Training for Brief Strategic Family Therapy (BSFT) for Adolescent Drug Abuse clinical trial, for members of the Clinical Trials Network, National Institutes on Drug Abuse.

March 2005 Adverse events and Serious Adverse Events General Concepts and Application in the Brief Strategic Family Therapy (BSFT) for Adolescent Drug Abuse clinical trial, for members of the Clinical Trials Network, National Institutes on Drug Abuse.

March 2005 Data Management and Clinical Data Collection for Brief Strategic 28 Family Therapy (BSFT) for Adolescent Drug Abuse clinical trial, for members of the Clinical Trials Network, National Institutes on Drug Abuse.

March 2005 Data Collection on Clinical Measures for Brief Strategic Family Therapy (BSFT) for Adolescent Drug Abuse clinical trial, for Therapists of the BSFT protocol, Clinical Trials Network, National Institutes on Drug Abuse.

March 2005 Recruitment, Retention and Follow up for Brief Strategic Family Therapy (BSFT) for Adolescent Drug Abuse clinical trial, for members of the Clinical Trials Network, National Institutes on Drug Abuse.

February 2005 Protocol Specific Training for Brief Strategic Family Therapy (BSFT) for Adolescent Drug Abuse clinical trial, for members of the Clinical Trials Network, National Institutes on Drug Abuse.

February 2005 Adverse events and Serious Adverse Events General Concepts and Application in the Brief Strategic Family Therapy (BSFT) for Adolescent Drug Abuse clinical trial, for members of the Clinical Trials Network, National Institutes on Drug Abuse.

February 2005 Data Management and Clinical Data Collection for Brief Strategic Family Therapy (BSFT) for Adolescent Drug Abuse clinical trial, for members of the Clinical Trials Network, National Institutes on Drug Abuse.

February 2005 Data Collection on Clinical Measures for Brief Strategic Family Therapy (BSFT) for Adolescent Drug Abuse clinical trial, for Therapists of the BSFT protocol, Clinical Trials Network, National Institutes on Drug Abuse.

February 2005 Recruitment, Retention and Follow up for Brief Strategic Family Therapy (BSFT) for Adolescent Drug Abuse clinical trial, for members of the Clinical Trials Network, National Institutes on Drug Abuse.

November 2004 Protocol Specific Training for Brief Strategic Family Therapy (BSFT) for Adolescent Drug Abuse clinical trial, for members of the Clinical Trials Network, National Institutes on Drug Abuse.

November 2004 Adverse events and Serious Adverse Events General Concepts and Application in the Brief Strategic Family Therapy (BSFT) for Adolescent Drug Abuse clinical trial, for members of the Clinical Trials Network, National Institutes on Drug Abuse.

November 2004 Data Management and Clinical Data Collection for Brief Strategic Family Therapy (BSFT) for Adolescent Drug Abuse clinical trial, for members of the Clinical Trials Network, National Institutes on Drug Abuse.

November 2004 Data Collection on Clinical Measures for Brief Strategic Family Therapy (BSFT) for Adolescent Drug Abuse clinical trial, for Therapists of the BSFT protocol, Clinical Trials Network, National Institutes on Drug Abuse. 29 November 2004 Recruitment, Retention and Follow up for Brief Strategic Family Therapy (BSFT) for Adolescent Drug Abuse clinical trial, for members of the Clinical Trials Network, National Institutes on Drug Abuse.

September 2004 Adverse events and Serious Adverse Events General Concepts and Application in the Brief Strategic Family Therapy (BSFT) for Adolescent Drug Abuse clinical trial, for members of the Clinical Trials Network, National Institutes on Drug Abuse. (2 trainings)

September 2004 Protocol Specific Training for Brief Strategic Family Therapy (BSFT) for Adolescent Drug Abuse clinical trial, for members of the Clinical Trials Network, National Institutes on Drug Abuse.

26e. Other teaching activities: Mentoring

Present- August 2020 Academic & Capstone Advisor for MPH student Lauran Crimmins Present- August 2020 Academic & Thesis Advisor for MSPH student Shavon Algee & Aliane Duyon Present -Fall 2019 Academic &Capstone Advisor for MPH/ MLAS student Aidan Wells June 2020 - November 2018 Advisor for MD/ MPH student Kayla Polcari. Present – August 2018 Academic & Capstone Advisor for MPH student Aderlie Acevedo Academic & Capstone Advisor for MPH student Sophie Cerbon- Gomez Academic & Thesis Advisor for Cindy Jacques Present – August 2017 Academic & Capstone Advisor Zhengis Makhambet

May 2020 – August 2018 Academic & Capstone Advisor for MPH student Renae Schmidt

Present- August 2017 Academic & Capstone Advisor for MPH student Kimberly Garces

May 2019- August 2017 Academic & Capstone Advisor for MPH student Justice King Academic & Capstone Advisor for MPH student Kiarabet Quintana Academic & Capstone Advisor for MPH student Erin Collier Academic & Thesis Advisor for MPH/MLAS student Jessica Orr May 2020- August 2016 Academic & Capstone Advisor for MPH student Daniel Samano May 2019 -August 2016 Academic & Capstone Advisor for MPH student Talia Hollzman December 2018- May 2012 Capstone Advisor for MPH student Amanda Leipold.

May 2018- August 2017 Academic Advisor for MPH student Dr Joan St Onge.

August 2018- August 2016 Academic &Thesis Advisor for MSPH student Blanca Noriega Academic &Capstone Advisor for MPH student Jacob Batycki July 2018- August 2015 Academic & Thesis Advisor for MSPH student Johnny Galli Academic & Thesis Advisor for MSPH student Yoselin Diaz Academic Thesis Advisor for MSPH student Xeniamaria Rodriguez 30 January 2018- August 2016 Academic and Capstone Advisor for MPH student Katelyn McGlynn August 2017- January 2016 Academic & Capstone Advisor for MPH student Olfat Atalla Academic & Capstone Advisor for MPH student Jasmine Green December 2016 - August 2014- Capstone Advisor for MPH student Cari Eckman Capstone Advisor for MPH student Ari Urbish Capstone Advisor for MPH student Danielle Rodriguez Capstone Advisor for MPH student Nagarjuna Sidhabathuna December 2015- September 2013 Capstone Advisor for MPH student John Salerno Capstone Advisor for MPH student Laurian Walters Capstone Advisor for MPH student Krystal Sardinas Capstone Advisor for MPH student Leighan Panico Capstone Advisor for MPH student Yanel Diaz Capstone Advisor for MPH student Alla Alghamendi Capstone Advisor for MPH student Lamia Houssain Capstone Advisor for MPH student Imelda Medina December 2015- January 2013 Capstone Advisor for MSPH student Angel Maldonado December 2014- June 2012 Capstone Advisor for MD/ MPH student Rammy Assaf. Capstone Advisor for MD/ MPH student Joanne Duara June 2014- September 2013 Capstone Advisor for MPH student Andres Von Watcher June 2014 - May 2013 Capstone Advisor for MPH student Irene Kirolos June 2014 -March 2013 Capstone Advisor for MPH student Rachel Nomberg Capstone Advisor for MPH student Paula Espinal Capstone Advisor for MPH student Karina Lizzi December 2013- January 2013 Capstone Advisor for MD/ MPH student Maryann Koussa. August 2013-January2013 Capstone Advisor for MPH student Larisa Topeka. August 2013- July 2012 Capstone Advisor for MPH student Vanessa Harrysingh. June 2012 Capstone Advisor for MPH student Joana Diaz. December 2012- 2009 Mark Stoutenberg, Ph.D., Research Assistant Professor, Department of Epidemiology and Public Health. CTN Scholar awardee. Mentoring on Clinical Trials methods and implementation.

26.e 1.Mentoring of International Researchers

Present- 2011 Rodrigo Marin Navarrete, Director for the Clinical Trials Unit, National Institute of Psychiatry in Mexico.

2017 - July 2015 Researchers at the Fundación San Carlos de Maipo, as part of the Technology Transfer for the implementation of the Familias Unidas Program, Santiago de Chile.

31 2016- July 2014 Researchers of the Human Research Council in South Africa, in Implementation Science, as part of the grant Implementing Comprehensive PMTCT & HIV Prevention for South African Couples –Collaboration for Implementation Science.

2016-July 2014 Researchers at the Universidad Católica Santiago de Guayaquil as part of the Technology Transfer for the implementation of the Familias Unidas Program Ecuador.

December 2016- March 2011 Researchers of the National Institute of Psychiatry in Mexico as part of the grant Technology Transfer for the Implementation of Randomized Clinical Trials with the NIDA CTN Standards at the National Institutes of Psychiatry in Mexico. Mentees: Dr Rodrigo Marin Navarrete, Dra Marcela Tiburcio, Dra Asunción Lara, Dr Ricardo Nani. Principal Investigator in Mexico Dr Maria Elena Medina Mora. Although the grant is finished, I continue to mentor the above-mentioned researchers and their students.

July 2012- July 2011 Maria Garcia Anaya, M.D., Ph.D., CTN Invest International Mexican Fellow. Mentoring on Clinical Trials methods, implementation and transfer of Technology with rigors of NIDA CTN.

June 2010- June 2009 Mario Zapata, Ph.D., CTN Invest Fellow. Mentoring on Clinical Trials methods and implementation.

a. Thesis and Dissertation Advising/Post-doctoral Student Supervision:

June 2016 Committee Member, "Substance Use and HIV Sexual Risk Behaviors among Vulnerable Populations: Substance Users, STD Clinic Patients and Hospitalized HIV-Infected Patients” Yue Pan Dissertation defense, University of Miami

VII. Service

b. University Committee and Administrative Responsibilities

27.a University of Miami

Present Director of Public Health Education, Department of Public Health Sciences, Miller School of Medicine, University of Miami

2020 Member of the Taskforce on Social Justice, Miller School of Medicine Curriculum Committee

Present- 2020 Member of the Advisory Board for the Master Program on Global Health 32 and Society, School of Arts and Sciences, University of Miami.

Present- 2020 Member of the Community Benefit Committee, Miller School of Medicine.

Present -2019 Member of the Accreditation Workgroup of the Department of Public Health Sciences, Miller School of Medicine, University of Miami.

2018- 2016 Interim Director of Public Health Education. Department of Public Health Sciences, Miller School of Medicine, University of Miami.

Present- 2018 Interviewer, Medical Admissions Committee, Miller School of Medicine.

Present- 2017 Member of the Graduate Council, Graduate School, University of Miami.

Present- 2016 Member of the Graduate Program Executive Committee, Graduate Programs, Department of Public Health Sciences, Miller School of Medicine, University of Miami.

Present -2016 Member of the Curriculum Committee, Graduate Programs, Department of Public Health Sciences, Miller School of Medicine, University of Miami.

Present- 2011 Capstone Committee Member and Advisor for the Department of Public Health Sciences, Miller School of Medicine, University of Miami.

2010- 2013 Member of the Admissions Committee for Miller School of Medicine.

Present – 2006 Executive Director for the Florida Node for the National Clinical Trials Network, University of Miami, Miller School of Medicine.

i. b. Professional Service

Present -2019 Advisory Council Member for the National Hispanic and Latino Addiction Technology Transfer Center Present -2019 Advisory Member of the National Hispanic and Latino Behavioral Health Association

Present- 2019 Member of the Scholarship of Teaching and Learning Task Force, Association of Schools and Programs in Public Health.

Present- 2016 Member of the Academic Affairs Section of the Association of Schools and Programs of Public Health

Present- 2018 Member of the Data Safety Monitoring Board for NIDA Grant R01 DA040756. Evaluating the Effectiveness of an eHealth EBI for Latino Youth in Primary Care Guillermo Prado, Principal Investigator.

Present- 2015 Member of the Editorial Board for the Journal Salud Mental

2021 Grant Reviewer, UM Provost of Research Awards

2021 Proposal Reviewer, UM Coastal Resilience Symposium

33 2020 Judge, Eastern Atlantic Student Research Symposium, Miller School of Medicine

2020 Peer review board member for grants submitted to the Canadian Health Research Institute, for the Canadian Research Initiative on Substance Misuse (CRISM), in response to COVID-19 RFP

2019 Grant Reviewer, Miami Institute of the Advanced Studies of the Americas

2019- 2017 Co- Chair of the Academic Affairs Section of the Association of Schools and Programs of Public Health

2016-2014 Peer review board member for grants submitted to the Canadian Health Research Institute, for the Canadian Research Initiative on Substance Misuse (CRISM).

2014 Program Chair of the National Conference of the National Hispanic and Latino Addiction Technology Transfer Center on Integrating Research, Education and Services to Reduce Behavioral Health Disparities in Hispanic and Latino Populations, Austin, Texas, October 8th and 9th.

2017-2013 Advisory Member for Latino and Hispanic Addiction Technology Transfer Center.

2015-2013 Member of the Data Safety Monitoring Board for grant NIDA, R01 DA032723, Family and Adolescent Motivational Incentives for Leveraging Youth. Michael Robbins, Principal Investigator.

2014 -2013 Member of the Data Safety Monitoring Board for NIDA R34 DA031973 Contingency Management for Smoking Cessation in Pregnant Minority Women Veronica Arcornero, Principal Investigator.

2013-2011 Member of the Data Safety Monitoring Board for grant NIDA R01 DA025894 “Preventing Drug Abuse and HIV in Hispanic First Offenders.” Guillermo Prado, PI.

2013-2011 Member of the Data Safety Monitoring Board for grant “Familias Unidas Stage III Study: Preventing Substance Use and HIV in Hispanic Youth.” Guillermo Prado, PI.

2011-2010 Co-Chair of the Psychology Interest Group of the National Drug Abuse Treatment Clinical Trials Network.

2012 Regional Advisory Council, Southern Coast Addiction Technology Transfer Centers.

2001-1999 Co-Investigator and Study Coordinator of Clinical Trials, Center for Clinical Research, Department of Psychiatry, Hospital Italiano de Buenos Aires, Argentina

1996 Organizing Committee Member for the Conference for Residents in Mental Health for the Buenos Aires Metropolitan Area

34 ii. Community Service:

2020 Volunteer Connect Familias, Holiday Toy Drive.

2019 - 2018 Member of the Opioid Task Force for Miami Dade County.

2018- 2017 President of the Music Magnet Parent Association

2014- 2012 Field Trip Sponsor, Pineview Preschools.

2014- 2012 Parent Reading Sessions for Toddlers and Preschoolers, Pineview Preschools. 2010 Coordinated series of day sailing trips for Veterans with PTSD and Substance Use disorders, in SSV Aventura.

35